Refractory splenectomized immune thrombocytopenic purpura: Does vincristine have a role after thrombopoietin receptor agonist failure?

Refractory splenectomized immune thrombocytopenic purpura: Does vincristine have a role after thrombopoietin receptor agonist failure?

Research Abstract

Objective

This study was done to assess the efficacy of vincristine in the treatment of patients with splenectomized chronic ITP who failed TPO-RA therapy as well as their 8-month follow-up following vincristine discontinuation.

Research Authors
Sawsan M Moeen, Ahmad F Thabet, Mohamed A Morad
Research Date
Research Department
Internal Medicine
Research Journal
The Egyptian Journal of Haematology
Research Member
Sawsan Mohamed Moeen Ibrahim
Research Pages
299-303
Research Publisher
Medknow
Research Vol
Volume 47, Issue 4
Research Website
https://scholar.google.com/scholar?oi=bibs&cluster=226425586651640466&btnI=1&hl=en
Research Year
2022